*/
Patent – Infringement. The Patents Court made rulings in proceedings concerning a patent owned by the defendant company, Eli Lilly, for a product used to treat lung cancer. It held that declarations of non-infringement would be granted in respect of each of the four designations of the patent in issue. Both parties would have permission to apply to the court in the event of a material change of circumstances. Further, declarations were made that two letters sent by Eli Lilly in the course of proceedings did not constitute legally binding undertakings.
Patent – Infringement. The Patents Court made rulings in proceedings concerning a patent owned by the defendant company, Eli Lilly, for a product used to treat lung cancer. It held that declarations of non-infringement would be granted in respect of each of the four designations of the patent in issue. Both parties would have permission to apply to the court in the event of a material change of circumstances. Further, declarations were made that two letters sent by Eli Lilly in the course of proceedings did not constitute legally binding undertakings.
Philip N Bristow explains how to unlock your aged debt to fund your tax in one easy step
With the property market witnessing significant changes since the beginning of the pandemic, Fleet Street Wealth’s Managing Director Julian Morgan considers the future of the home, the second home and the office
In partnership with the Bar Council, LexisNexis is offering up to 60% off its extensive webinar offering.
Chambers is expanding its team.
Making a move from the Bar to a career in governance: Maria Brookes outlines three good reasons to switch and how to do it
Making sure international justice works effectively and realising what matters Karim Khan QC, the new Chief Prosecutor at the International Criminal Court, talks to Monica Feria-Tinta
Twelve leading trial lawyers shared their advocacy tips with the Advocacy Podcast a distillation of their advice, by Bibi Badejo, Justin Tadros, Alex Cameron and Antonia Eklund
Exclusive statistical analysis: Barbara Mills QC outlines how the deeply unhelpful, homogenous BAME acronym is masking the true extent and systemic nature of the Bars diversity problem
A toolkit to help you build profile, expertise and a bright future in arbitration. By James Bridgeman
